The Law Offices of Frank R. Cruz continues its investigation of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) on behalf of investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.

What Is The Investigation About?

On July 22, 2025, Blue Orca Capital published a report alleging, among other things, that Nutex’s share price has “surged” after it “began submitting the majority of its patient bills to the arbitration process for settling out-of-network medical bills . . . using an unidentified ‘third party IDR vendor.’” The report further states that the “mystery consultant” is HaloHD, which, according to multiple lawsuits, has “engag[ed] in a coordinated fraudulent scheme to steal millions of dollars from insurance companies on behalf of and in conjunction with its healthcare billing clients.”

On this news, Nutex’s stock price fell $11.18, or 10.1%, to close at $100.01 per share on July 22, 2025, thereby injuring investors.

On August 14, 2025, Nutex announced it would delay filing its quarterly financial statements for the period ending June 30, 2025, “due to additional time needed to analyze classification of certain equity instruments and finalize its financial statements.”

On this news shares fell $18.22, or 16.4%, to close at $92.91 on August 15, 2025, thereby injuring investors further.

Contact Us To Participate or Learn More:

If you purchased Nutex securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

The Law Offices of Frank R. Cruz,

2121 Avenue of the Stars, Suite 800,

Century City, California 90067

Call us at: 310-914-5007

Email us at: info@frankcruzlaw.com

Visit our website at: www.frankcruzlaw.com.

Follow us for updates on Twitter at twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250818248609/en/